Literature DB >> 17127191

Gallstone disease. Management of common bile-duct stones and associated gallbladder stones: Surgical aspects.

Djamila Boerma1, Matthijs P Schwartz.   

Abstract

For many years, open exploration of the common bile duct has been the treatment of choice for patients with common bile-duct stones. During recent decades endoscopic sphincterotomy has gained wide acceptance as an effective and less invasive alternative. After sphincterotomy, subsequent (laparoscopic) cholecystectomy is warranted in patients with gallbladder stones. This chapter will discuss whether sphincterotomy should be performed prior to, during or after cholecystectomy, and will also address the question of whether single-stage treatment by laparoscopic cholecystectomy and laparoscopic bile-duct exploration is in fact preferable. The rate of recurrent choledocholithiasis after endoscopic biliary sphincterotomy can reach more than 20%. This review focuses on the risk factors--delayed bile-duct clearance and bactobilia--that may lead to recurrent primary bile-duct stone formation. Underlying altered bile composition (relative phospholipid deficiency) should be recognised in a subgroup of patients. Identification of these risk factors may significantly affect treatment policy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17127191     DOI: 10.1016/j.bpg.2006.04.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  8 in total

1.  Timing of elective laparoscopic cholecystectomy after endoscopic retrograde cholangiopancreaticography with sphincterotomy: a prospective observational study of 308 patients.

Authors:  Erdal Birol Bostanci; Metin Ercan; Ilter Ozer; Zafer Teke; Erkan Parlak; Musa Akoglu
Journal:  Langenbecks Arch Surg       Date:  2010-06-06       Impact factor: 3.445

Review 2.  Transcystic or transductal stone extraction during single-stage treatment of choledochocystolithiasis: a systematic review.

Authors:  Jan Siert K Reinders; Dirk J Gouma; Dirk T Ubbink; Bert van Ramshorst; Djamila Boerma
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

3.  "Ultra-rapid" sequential treatment in cholecystocholedocholithiasis: alternative same-day approach to laparoendoscopic rendezvous.

Authors:  Dario Borreca; Alberto Bona; Maria Paola Bellomo; Andrea Borasi; Paolo De Paolis
Journal:  Updates Surg       Date:  2015-12-11

4.  Open common bile duct exploration without T-tube insertion- two decade experience from a limited resource setting in the Caribbean.

Authors:  Vijay Naraynsingh; Seetharaman Hariharan; Michael J Ramdass; Dilip Dan; Parul Shukla; Ravi Maharaj
Journal:  Indian J Surg       Date:  2010-08-26       Impact factor: 0.656

5.  Cardiovascular complications after common bile duct stone extractions.

Authors:  Eva-Lena Syrén; Lars Enochsson; Staffan Eriksson; Arne Eklund; Bengt Isaksson; Gabriel Sandblom
Journal:  Surg Endosc       Date:  2020-07-01       Impact factor: 4.584

6.  Surgical (Open and laparoscopic) management of large difficult CBD stones after different sessions of endoscopic failure: A retrospective cohort study.

Authors:  Emad Hamdy Gad; Hazem Zakaria; Yasmin Kamel; Ayman Alsebaey; Talat Zakareya; Mohamed Abbasy; Anwar Mohamed; Ali Nada; Mohammed Alsayed Abdelsamee; Mohamed Housseni
Journal:  Ann Med Surg (Lond)       Date:  2019-05-31

7.  Various techniques for the surgical treatment of common bile duct stones: a meta review.

Authors:  Abolfazl Shojaiefard; Majid Esmaeilzadeh; Ali Ghafouri; Arianeb Mehrabi
Journal:  Gastroenterol Res Pract       Date:  2009-08-06       Impact factor: 2.260

8.  Percutaneous transhepatic papilla balloon dilatation combined with a percutaneous transcystic approach for removing concurrent gallbladder stone and common bile duct stone in a patient with billroth II gastrectomy and acute cholecystitis: A case report.

Authors:  Dong Li; Yu-Liang Li; Wu-Jie Wang; Bin Liu; Hai-Yang Chang; Wei Wang; Yong-Zheng Wang; Zheng Li
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.